Actionable news
All posts from Actionable news
Actionable news in SGNL: SIGNAL GENETICS Inc,

Signal Genetics Expands Reimbursement of MyPRS(R) With Additional Preferred Provider Organization Agreements

CARLSBAD, Calif., Oct. 20, 2015 (GLOBE NEWSWIRE) -- Signal Genetics, Inc. (SGNL) (Signal), a commercial stage, molecular genetics diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer, today announced the signing of additional preferred provider organization (PPO) agreements.

Under the terms of the agreements, the Signal Genetics MyPRS(R) assay will be offered through additional PPO networks including the Stratose, USA Managed Care Organization, and Evolutions Healthcare Systems PPO networks. These new agreements will provide coverage to over 21 million patients across the United States.

Tamara A. Seymour, Chief Financial Officer, commented, "We are pleased to continue the expansion of our partnerships with provider networks, as the signing of these agreements will further enhance and simplify our reimbursement process. With strong partnerships and a streamlined reimbursement procedure, we expect to see additional revenue recovery from these initiatives. In addition, these recent agreements demonstrate our ability to continue to execute our growth strategy. Together with the PPO agreement we announced earlier this year and our other payor relationships with Medicare and Blue...